|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,583,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,917,000 |
Avg
Vol: |
859,049 |
52
Week Range: |
$259.55 - $259.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Zanganeh Maky |
Chief Operating Officer |
|
2014-11-07 |
4 |
S |
$135.01 |
$209,401 |
D/D |
(1,551) |
210,312 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-11-07 |
4 |
OE |
$2.30 |
$3,567 |
D/D |
1,551 |
211,863 |
|
- |
|
Fardis Maria |
Chief of Oncology Ops & Allian |
|
2014-11-07 |
4 |
S |
$134.50 |
$672,500 |
D/D |
(5,000) |
3,193 |
|
- |
|
Fardis Maria |
Chief of Oncology Ops & Allian |
|
2014-11-07 |
4 |
OE |
$6.84 |
$34,200 |
D/D |
5,000 |
8,193 |
|
- |
|
Tan Heow |
Chief Quality&Tech Operations |
|
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
4,070 |
|
- |
|
Fardis Maria |
Chief of Oncology Ops & Allian |
|
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
3,193 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
210,312 |
|
- |
|
Love Richard B |
General Counsel |
|
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
205 |
|
- |
|
Soni Manmeet Singh |
Chief Financial Officer |
|
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
38,611 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2014-09-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
13,424,589 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2014-09-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
13,431,589 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2014-09-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
13,441,589 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2014-09-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,450 |
13,442,589 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2014-09-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,413 |
13,448,039 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-09-04 |
4 |
S |
$122.00 |
$610,000 |
D/D |
(5,000) |
210,311 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-09-04 |
4 |
OE |
$2.30 |
$11,500 |
D/D |
5,000 |
215,311 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-09-03 |
4 |
S |
$121.10 |
$850,980 |
D/D |
(7,000) |
210,311 |
|
- |
|
Zanganeh Maky |
Chief Operating Officer |
|
2014-09-03 |
4 |
OE |
$2.30 |
$16,100 |
D/D |
7,000 |
217,311 |
|
- |
|
Love Richard B |
General Counsel |
|
2014-08-27 |
4 |
S |
$124.00 |
$186,000 |
D/D |
(1,500) |
204 |
|
- |
|
Love Richard B |
General Counsel |
|
2014-08-27 |
4 |
OE |
$32.38 |
$48,570 |
D/D |
1,500 |
1,704 |
|
- |
|
Tan Heow |
Chief Quality&Tech Operations |
|
2014-08-21 |
4 |
OE |
$27.05 |
$59,402 |
D/D |
2,196 |
4,069 |
|
- |
|
Tomasello Shawn |
Chief Commercial OfficerOffice |
|
2014-08-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
202 |
|
- |
|
Tomasello Shawn |
Chief Commercial Officer |
|
2014-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
62,500 |
|
- |
|
Fardis Maria |
Chief of Oncology Ops & Allian |
|
2014-08-13 |
4 |
S |
$121.01 |
$484,040 |
D/D |
(4,000) |
3,192 |
|
- |
|
Fardis Maria |
Chief of Oncology Ops & Allian |
|
2014-08-13 |
4 |
OE |
$6.84 |
$27,360 |
D/D |
4,000 |
7,192 |
|
- |
|
80 Records found
|
|
Page 3 of 4 |
|
|